Puredrug

Puredrug, a large pharmaceutical company that has recently fallen on hard times, has the chance to sigh an $8 million sales contract with the Philippine Government for a new drug called Travenol used for treating viral infections, including measles. Purdrug's inventory includes a large batch of Travenol that was rejected by the U.S. Government based off a very sensitive test for toxic substances. This sensitive test found low dose of a toxic substance called endotoxin in the batch of Travenol, a level that would not have been caught using the old test. As the Phillipines rely solely on the old test, it would not be detected. Endotoxin causes a high fever, but no one can say if Puredrug's batch of Travenol contains enough endotoxin in patients. Last year half of the Philippine children who contracted measles died.